CN Patent

CN110536694A — 用于治疗肺部炎症的组合物和方法

Assigned to Atyr Pharmaceutical Co · Expires 2019-12-03 · 6y expired

What this patent protects

提供了用于治疗肺部炎症(包含间质性肺病(ILD))的疗法(包含联合疗法)，其包含单独使用至少一种组氨酰‑tRNA合成酶(HRS)多肽或编码所述HRS多肽的可表达多核苷酸，或将其与至少一种免疫调节剂组合使用。

USPTO Abstract

提供了用于治疗肺部炎症(包含间质性肺病(ILD))的疗法(包含联合疗法)，其包含单独使用至少一种组氨酰‑tRNA合成酶(HRS)多肽或编码所述HRS多肽的可表达多核苷酸，或将其与至少一种免疫调节剂组合使用。

Drugs covered by this patent

Patent Metadata

Patent number: CN110536694A
Jurisdiction: CN
Classification: —
Expires: 2019-12-03
Drug substance claim: No
Drug product claim: No
Assignee: Atyr Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.